Prof. Zeynep Karaali is an experienced internal medicine physician with a strong clinical background and dedication to patient-centered care. She completed her internal medicine training at Taksim Training and Research Hospital in 2002 and has continued to build her practice and expertise over the years. In 2024 she joined Acıbadem Health Group, where she contributes to high-quality medical services and multidisciplinary collaboration. Prof. Karaali is an active member of the Turkish Medical Association and the Internal Medicine Association, reflecting her commitment to professional development and the broader medical community. Her work focuses on evidence-based diagnosis and treatment, compassionate patient care, and ongoing engagement with advances in internal medicine.
Education
- 2002 Taksim Training and Research Hospital Internal Medicine
- 1995 Istanbul University Cerrahpasa Faculty of Medicine
Experience
- 2024 Acibadem Health Group
- 2020 – 2024 Başakşehir Çam and Sakura City Hospital Internal Medicine Clinic / Internal Medicine Training and Administrative Officer
- 2020 Haseki Training and Research Hospital Internal Medicine Clinic / Internal Medicine Professor Doctor
- 2016 – 2020 Haseki Training and Research Hospital Internal Medicine Clinic / Internal Medicine Training Supervisor
- 2012 Haseki Training and Research Hospital Internal Medicine Clinic / Internal Medicine Training Assistant
- 2012 Haseki Training and Research Hospital Internal Medicine Clinic / Internal Medicine Associate Professor Doctor
- 2002 – 2010 Haseki Training and Research Hospital l. Internal Diseases Clinic / Internal Diseases Specialist (Chief Assistant)
- 1997 – 2002 Taksim Training and Research Hospital 2nd Internal Medicine Clinic / Internal Medicine Assistant
- 1996 – 1997 Turkish Kidney Foundation Ahmet Ermis Dialysis Center / General Practitioner
Memberships
- Turkish Medical Association
- Internal Medicine Association
Publications
- Inclusion body myositis triggcrrcd with long-term imatinib usc.
J Oncol Pharm Pract. 2023 Apr 10:10781552231168563. doi: 10.1177/10781552231168563. Deniz R, Güzelbey T, Narinoğlu S, Şirin Kalem G, Ekmen ŞA, Gündoğdu Ünverengil G, Karaali Z. - The Evaluation of the Role of (Pro)hcpcidin in Anemia Encountercd in Inflammatory Bowel Diseascs
J Clin Pract Res 2023; 45(3): 222-6 DOI: 10.14744/ctd.2022.95881 Acar S, Akyildiz M , Karaali Z, Poturoglu S. - Gastric Actinomycosis Rescmbling a Mass Prcsents with Upper Gastrointestinal BlcedingDiagnostic and Intcrventional Endoscopy.
Diagn Intcrv Endosc. 2022; 1 (3):87-88 Irak K, Karamangil EZ, Dursun N, Karaali Z, Poturoglu P. - Role of anklc brachial index measured by simple automatic sphygmomanomcters in predieting postoperativc kidney funetion in patients undergoing major cardiac surgery
Rev Nefrol Dial Transp.2021 ;41 (3): 192-201 Abdullah Sumnu, Savaş Ozturk, Eyüp Cavdar.Fatma Tuba Mert, Egemen Cebeci, Zeynep Karaali, Mazlum Sahin - Investigation of metabolic effects of CETP gene rs289714 variation in coronary artery disease patients: A case-control study
Archives of Turkish Society of Cardiology 2020;48(7):673-682 Kurnaz Gömleksiz Özlem, Karaali Zeynep, Buğra Melike Zehra, Öztürk Oğuz, Yılmaz Aydoğan Hülya - Serum sirtuin 1 protein as a potential biomarker for type 2 diabetes: Increased expression of sirtuin 1 and the correlation with microRNAs
J Res Med Sci. 2019 Jun 25;24:56 Gok O, Karaali Z, Ergen A, Ekmekçi SS, Abaci N. - Toll -Likc Rcccptor2 (TLR-2) gene Polymorphism im Type 2 Diabetes Mellitus
Celi J, 2019, 20 (4): 559-563 Karaali Z, Candan G, Aktuglu MB, Velet M.Ergcn A. - Association bctwccn polymorphisms of DNA icpair genes and risk of typc 2 diabetes mellitus in The Turkish population
Turk J Biochcm 2017; doi 10.1515/tjb-2016-0107 Tokmak N, Yilmaz U, Yilmaz, N Yurdum LM, Yigitbasi N, Ergen HE, Karaali Z, Zeybek SU. - Changes in the inflammatory markers with advancing stages of diabetic nephropathy and the role of pentraxin-3.Rei Fail
2016 Jul 19:1-6. Uzun S, Ozari M, Gursu M, Karadağ S, Behlul A, Sari S, Koldaş M, Demir S, Karaali Z, Ozturk S. - rs3767140 SNP of the perlecan (HSPG2) gene affect the diabetes mellitus thıough the dyslipidemia?
Celi. Mol. Biol.2016, 62 (8): 35-39 Kumaz-Gömleksiz O, Tokat B, Aslan E.l, Yanar F, Ermiş-Karaali Z, Öztürk O, Yilmaz-Aydoğan H. Can
